Glucose Sensing and Hexokinases in the African Trypanosome
非洲锥虫中的葡萄糖传感和己糖激酶
基本信息
- 批准号:9900822
- 负责人:
- 金额:$ 22.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至 2022-07-14
- 项目状态:已结题
- 来源:
- 关键词:Africa South of the SaharaAfricanAfrican TrypanosomiasisAreaBiochemicalBiologyBlood CirculationCell physiologyCellular biologyCenters of Research ExcellenceCollaborationsComplexCore FacilityCuesDataDetergentsDevelopmentDiseaseDistantEctopic ExpressionEnvironmentEnzymesFundingGenerationsGeneticGlucoseGlycolysisGlycosomeGoalsHexokinase 2HumanImmunochemistryInfrastructureInsectaLaboratoriesLife Cycle StagesLightMammalsMeasuresMediatingMentorsMentorshipMetabolismMicroscopyMissionMitochondriaMolecularNutrientOrganellesOutcomeParasitesPathway interactionsProcessProteinsPublic HealthPublicationsRegulationResearchResearch PersonnelResolutionRiskRoleTestingTrypanosomaTrypanosoma brucei bruceiTsetse FliesUnited States National Institutes of HealthUniversitiesVoltage-Dependent Anion ChannelWorkbaseenzyme activityglucose metabolismhexokinaseimaging facilitiesinfection riskinnovationinterestkinetosomematriculationneglected tropical diseasesnew therapeutic targetpathogenperoxisomeprogramsresponsetherapeutic developmentunpublished works
项目摘要
PROJECT SUMMARY/ABSTRACT
The infectious lifecycle stage of the African trypanosome, Trypanosoma brucei, relies exclusively on glycolysis
for ATP generation. The parasite responds to dynamic environmental cues to regulate this pathway. The goal
of this application is to resolve the mechanisms that regulate localization of the essential glycolytic enzymes, T.
brucei hexokinase 1 and 2, with a particular emphasis on understanding the glucose-sensitive subcellular
localization of the proteins. We have previously demonstrated that T. brucei hexokinase 2, which was
heretofore believed to be limited in its distribution to a peroxisome-like organelle called the glycosome, has in
addition a life-cycle dependent extra-glycosomal localization. In the bloodstream form parasites, the protein
was found in the flagellum while in the insect stage the protein was found proximal to the basal bodies. Our
preliminary data suggests that the localization is dependent on environmental glucose availability and that the
hexokinases are associated with a detergent-insoluble fraction of the mitochondria. Using both ectopic
expression of tagged proteins and immunochemistry in collaboration with microscopy and biochemical
approaches, we will identify the enzyme domains that are required for localization. Additionally, we will begin to
resolve the mechanisms required for glucose-dependent localization, with a particular focus on the association
of the hexokinases with the parasite mitochondrion. Through these studies, new ways of targeting glucose
metabolism, an essential parasite pathway, will be identified.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES Culvin MORRIS其他文献
JAMES Culvin MORRIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES Culvin MORRIS', 18)}}的其他基金
Enolase inhibitors as therapeutic leads for Naegleria fowleri infections
烯醇酶抑制剂作为福氏耐格里阿米巴感染的治疗先导药物
- 批准号:
10739388 - 财政年份:2023
- 资助金额:
$ 22.11万 - 项目类别:
Approaches for genetic manipulation of Naegleria fowleri
福氏耐格里虫的基因操作方法
- 批准号:
10641130 - 财政年份:2023
- 资助金额:
$ 22.11万 - 项目类别:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
COBRE:真核病原体创新中心(EPIC)
- 批准号:
10494462 - 财政年份:2022
- 资助金额:
$ 22.11万 - 项目类别:
Acquisition of the Agilent Cytation C10 confocal imaging reader for enhancing biomedical research excellence at Clemson University
采购 Agilent Cytation C10 共焦成像阅读器,以提高克莱姆森大学的生物医学研究卓越性
- 批准号:
10798537 - 财政年份:2022
- 资助金额:
$ 22.11万 - 项目类别:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
COBRE:真核病原体创新中心(EPIC)
- 批准号:
10666653 - 财政年份:2022
- 资助金额:
$ 22.11万 - 项目类别:
Nutrient sensing and hexokinases in T. brucei
T. brucei 中的营养感应和己糖激酶
- 批准号:
7911534 - 财政年份:2009
- 资助金额:
$ 22.11万 - 项目类别:
Nutrient sensing and hexokinases in T. brucei
T. brucei 中的营养感应和己糖激酶
- 批准号:
7454845 - 财政年份:2008
- 资助金额:
$ 22.11万 - 项目类别:
Identification of Inhibitors of Trypanosoma Brucei Hexokinases
布氏锥虫己糖激酶抑制剂的鉴定
- 批准号:
7459260 - 财政年份:2007
- 资助金额:
$ 22.11万 - 项目类别:
Glucose Sensing and Hexokinases in the African Trypanosome
非洲锥虫中的葡萄糖传感和己糖激酶
- 批准号:
9261578 - 财政年份:
- 资助金额:
$ 22.11万 - 项目类别:
相似海外基金
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
- 批准号:
10511408 - 财政年份:2022
- 资助金额:
$ 22.11万 - 项目类别:
A One Health approach to investigating the ecology of East African trypanosomiasis in Malawian wildlife
调查马拉维野生动物中东非锥虫病生态学的“同一个健康”方法
- 批准号:
476178 - 财政年份:2022
- 资助金额:
$ 22.11万 - 项目类别:
Studentship Programs
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
- 批准号:
10677879 - 财政年份:2022
- 资助金额:
$ 22.11万 - 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
- 批准号:
10466942 - 财政年份:2021
- 资助金额:
$ 22.11万 - 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
- 批准号:
10296873 - 财政年份:2021
- 资助金额:
$ 22.11万 - 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
- 批准号:
10706306 - 财政年份:2021
- 资助金额:
$ 22.11万 - 项目类别:
Reducing and replacing the animal cost of functional genetics in African trypanosomiasis
减少和替代非洲锥虫病功能遗传学的动物成本
- 批准号:
NC/W001144/1 - 财政年份:2021
- 资助金额:
$ 22.11万 - 项目类别:
Research Grant
Development of new drug for African trypanosomiasis based on elucidation of the mechanism of antiprotozoal action by ribavirin.
基于利巴韦林抗原虫作用机制的阐明,开发治疗非洲锥虫病的新药。
- 批准号:
21K18230 - 财政年份:2021
- 资助金额:
$ 22.11万 - 项目类别:
Grant-in-Aid for Challenging Research (Pioneering)
Development of a novel control measure for African trypanosomiasis based on the blocking of lifecycle progression
基于生命周期进展阻断的非洲锥虫病新型控制措施的开发
- 批准号:
20K07467 - 财政年份:2020
- 资助金额:
$ 22.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Drug-diagnostic co-development in Tropical Medicine, combating Human African Trypanosomiasis
热带医学药物诊断联合开发,抗击非洲人类锥虫病
- 批准号:
18KK0454 - 财政年份:2019
- 资助金额:
$ 22.11万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))